NASDAQ:HCAT Health Catalyst (HCAT) Stock Forecast, Price & News $12.00 +0.73 (+6.48%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$11.41▼$12.0250-Day Range$9.86▼$13.1252-Week Range$6.40▼$18.30Volume387,792 shsAverage Volume484,443 shsMarket Capitalization$675.12 millionP/E RatioN/ADividend YieldN/APrice Target$15.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Health Catalyst MarketRank™ ForecastAnalyst RatingHold2.43 Rating ScoreUpside/Downside25.0% Upside$15.00 Price TargetShort InterestHealthy3.16% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews Sentiment0.90Based on 3 Articles This WeekInsider TradingAcquiring Shares$499,820 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.09) to ($1.02) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.43 out of 5 starsMedical Sector168th out of 983 stocksComputer Programming, Data Processing, & Other Computer Related Industry10th out of 60 stocks 3.2 Analyst's Opinion Consensus RatingHealth Catalyst has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 6 buy ratings, 8 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $15.00, Health Catalyst has a forecasted upside of 25.0% from its current price of $12.00.Amount of Analyst CoverageHealth Catalyst has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.16% of the outstanding shares of Health Catalyst have been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Health Catalyst has recently increased by 2.30%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreHealth Catalyst has received a 48.83% net impact score from Upright. Health Catalyst seems to create the most significant positive value in categories "Taxes", "Creating knowledge", and "Physical diseases". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Health data collection software", "Data analytics services", and "Drug discovery software" products. See details.Environmental SustainabilityThe Environmental Impact score for Health Catalyst is -0.91. Previous Next 3.3 News and Social Media Coverage News SentimentHealth Catalyst has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Health Catalyst this week, compared to 3 articles on an average week.Search Interest2 people have searched for HCAT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have bought more of their company's stock than they have sold. Specifically, they have bought $499,820.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.50% of the stock of Health Catalyst is held by insiders.Percentage Held by Institutions90.55% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($1.09) to ($1.02) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -4.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -4.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Health Catalyst (NASDAQ:HCAT) StockHealth Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.Read More Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Email Address HCAT Stock News HeadlinesMay 28, 2023 | americanbankingnews.comAnalysts Set Health Catalyst, Inc. (NASDAQ:HCAT) Price Target at $14.75May 18, 2023 | americanbankingnews.comHealth Catalyst, Inc. (NASDAQ:HCAT) Short Interest UpdateJune 4, 2023 | Vantage Point (Ad)We Called (ARWR) In Advance, Which Stocks Are Next?Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE. May 17, 2023 | americanbankingnews.comHealth Catalyst (NASDAQ:HCAT) Trading Up 8.1% Following Insider Buying ActivityMay 15, 2023 | finance.yahoo.comCEO & Director of Health Catalyst Picks Up 6.9% More Stock \May 15, 2023 | americanbankingnews.comHealth Catalyst, Inc. (NASDAQ:HCAT) CEO Acquires $499,819.50 in StockMay 14, 2023 | americanbankingnews.comHealth Catalyst (NASDAQ:HCAT) Shares Gap Up on Insider Buying ActivityMay 12, 2023 | msn.comGuggenheim Downgrades Health Catalyst (HCAT)June 4, 2023 | Vantage Point (Ad)We Called (ARWR) In Advance, Which Stocks Are Next?Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE. May 11, 2023 | msn.comRBC Capital Maintains Health Catalyst (HCAT) Sector Perform RecommendationMay 10, 2023 | markets.businessinsider.comHealth Catalyst's Q1 Earnings: Analysts Diverge on Outlook as Company Faces Demand Headwinds and Revenue OutperformanceMay 10, 2023 | theglobeandmail.comWhy Health Catalyst (HCAT) Shares Are Plunging TodayMay 10, 2023 | americanbankingnews.comRaymond James Lowers Health Catalyst (NASDAQ:HCAT) to Market PerformMay 10, 2023 | americanbankingnews.comHealth Catalyst (NASDAQ:HCAT) Downgraded to "Neutral" at GuggenheimMay 10, 2023 | finanznachrichten.deHealth Catalyst, Inc.: Health Catalyst Reports First Quarter 2023 ResultsMay 10, 2023 | markets.businessinsider.comAnalysts Offer Insights on Technology Companies: Health Catalyst (HCAT), ForgeRock Inc (FORG) and GlobalFoundries Inc (GFS)May 9, 2023 | theglobeandmail.comHealth Catalyst's (NASDAQ:HCAT) Q1 Sales Top EstimatesMay 9, 2023 | finance.yahoo.comHealth Catalyst (HCAT) Tops Q1 Earnings and Revenue EstimatesMay 9, 2023 | finance.yahoo.comCompared to Estimates, Health Catalyst (HCAT) Q1 Earnings: A Look at Key MetricsMay 9, 2023 | finance.yahoo.comHealth Catalyst Reports First Quarter 2023 ResultsMay 9, 2023 | finance.yahoo.comSea Mar Community Health Centers and Health Catalyst Partner to Advance Healthcare in Underserved CommunitiesMay 9, 2023 | markets.businessinsider.comHealth Catalyst earnings preview: what Wall Street is expectingMay 9, 2023 | omaha.com050923-owh-new-catalyst-pic-cm12May 8, 2023 | omaha.comPhotos: UNMC Catalyst project to rise out of Omaha Steel Castings siteMay 3, 2023 | americanbankingnews.comAnalysts Set Health Catalyst, Inc. (NASDAQ:HCAT) Target Price at $15.00April 25, 2023 | finance.yahoo.comHealth Catalyst to Announce First Quarter 2023 Operating Results and Host Conference Call on Tuesday, May 9, 2023April 21, 2023 | msn.comKeybanc Upgrades Health Catalyst (HCAT)See More Headlines HCAT Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HCAT Company Calendar Last Earnings5/09/2023Today6/03/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Computer programming, data processing, & other computer related Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HCAT CUSIPN/A CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,200Year FoundedN/APrice Target and Rating Average Stock Price Forecast$15.00 High Stock Price Forecast$18.00 Low Stock Price Forecast$8.00 Forecasted Upside/Downside+25.0%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage14 Analysts Profitability EPS (Most Recent Fiscal Year)($2.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-137,400,000.00 Net Margins-52.53% Pretax Margin-52.76% Return on Equity-17.45% Return on Assets-9.82% Debt Debt-to-Equity Ratio0.56 Current Ratio4.24 Quick Ratio4.24 Sales & Book Value Annual Sales$276.24 million Price / Sales2.44 Cash FlowN/A Price / Cash FlowN/A Book Value$7.20 per share Price / Book1.67Miscellaneous Outstanding Shares56,260,000Free Float55,416,000Market Cap$675.12 million OptionableNot Optionable Beta1.24 Key ExecutivesDaniel D. BurtonChief Executive Officer & DirectorAnne Marie BickmoreChief Operating & Product OfficerBryan HuntChief Financial OfficerJason JonesChief Analytics & Data Science OfficerMelissa WelchChief Medical OfficerKey CompetitorsAmerican WellNYSE:AMWLEditas MedicineNASDAQ:EDITGeneluxNASDAQ:GNLXEdgewise TherapeuticsNASDAQ:EWTXTheravance BiopharmaNASDAQ:TBPHView All CompetitorsInsiders & InstitutionsAmeriprise Financial Inc.Bought 70,173 shares on 5/22/2023Ownership: 0.634%New York State Common Retirement FundBought 19,048 shares on 5/18/2023Ownership: 0.199%Bares Capital Management Inc.Sold 2,400 shares on 5/16/2023Ownership: 0.800%BlueCrest Capital Management LtdBought 19,800 shares on 5/16/2023Ownership: 0.035%Segall Bryant & Hamill LLCSold 20,000 shares on 5/16/2023Ownership: 0.034%View All Insider TransactionsView All Institutional Transactions HCAT Stock - Frequently Asked Questions Should I buy or sell Health Catalyst stock right now? 14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 8 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HCAT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HCAT, but not buy additional shares or sell existing shares. View HCAT analyst ratings or view top-rated stocks. What is Health Catalyst's stock price forecast for 2023? 14 brokerages have issued 1 year price objectives for Health Catalyst's shares. Their HCAT share price forecasts range from $8.00 to $18.00. On average, they anticipate the company's share price to reach $15.00 in the next twelve months. This suggests a possible upside of 25.0% from the stock's current price. View analysts price targets for HCAT or view top-rated stocks among Wall Street analysts. How have HCAT shares performed in 2023? Health Catalyst's stock was trading at $10.63 on January 1st, 2023. Since then, HCAT shares have increased by 12.9% and is now trading at $12.00. View the best growth stocks for 2023 here. When is Health Catalyst's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our HCAT earnings forecast. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) posted its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.20) earnings per share for the quarter, topping the consensus estimate of ($0.34) by $0.14. The firm earned $73.87 million during the quarter, compared to the consensus estimate of $71.16 million. Health Catalyst had a negative trailing twelve-month return on equity of 17.45% and a negative net margin of 52.53%. What ETFs hold Health Catalyst's stock? ETFs with the largest weight of Health Catalyst (NASDAQ:HCAT) stock in their portfolio include ROBO Global Healthcare Technology and Innovation ETF (HTEC), Fidelity Digital Health ETF (FDHT), SPDR FactSet Innovative Technology ETF (XITK), Invesco Raymond James SB-1 Equity ETF (RYJ), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and iShares U.S. Healthcare Providers ETF (IHF) and What guidance has Health Catalyst issued on next quarter's earnings? Health Catalyst issued an update on its second quarter 2023 earnings guidance on Tuesday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $70.30 million-$74.30 million, compared to the consensus revenue estimate of $72.78 million. What is Dan Burton's approval rating as Health Catalyst's CEO? 501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL). When did Health Catalyst IPO? (HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. What is Health Catalyst's stock symbol? Health Catalyst trades on the NASDAQ under the ticker symbol "HCAT." Who are Health Catalyst's major shareholders? Health Catalyst's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.44%), First Light Asset Management LLC (3.52%), Daventry Group LP (2.91%), State Street Corp (2.48%), Geode Capital Management LLC (1.92%) and Balyasny Asset Management L.P. (1.87%). Insiders that own company stock include Anita Pramoda, Bryan Richard Hinton, Bryan Truman Hunt, D Fraser Bullock, Dale Sanders, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn, Paul Horstmeier and Timothy G Ferris. View institutional ownership trends. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Health Catalyst's stock price today? One share of HCAT stock can currently be purchased for approximately $12.00. How much money does Health Catalyst make? Health Catalyst (NASDAQ:HCAT) has a market capitalization of $675.12 million and generates $276.24 million in revenue each year. The company earns $-137,400,000.00 in net income (profit) each year or ($2.72) on an earnings per share basis. How many employees does Health Catalyst have? The company employs 1,200 workers across the globe. How can I contact Health Catalyst? Health Catalyst's mailing address is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. The official website for the company is www.healthcatalyst.com. The company can be reached via phone at (801) 708-6800 or via email at ir@healthcatalyst.com. This page (NASDAQ:HCAT) was last updated on 6/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.